Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
FUT2 non-secretor status is not associated with disease phenotype or outcomes in patients with Crohn's disease.
Journal: Crohn's & colitis 360
Published: September 29, 2025
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium.
Journal: Inflammatory bowel diseases
Published: November 06, 2023
Delays in definitive endoscopic resection of previously manipulated colorectal polyps as a risk factor for inferior resection outcomes.
Journal: Gastrointestinal endoscopy
Published: August 20, 2023
Editorial: response to tofacitinib is associated with high rates of long-term treatment persistence.
Editorial: response to tofacitinib is associated with high rates of long-term treatment persistence.
Journal: Alimentary pharmacology & therapeutics
Published: March 03, 2022
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: July 12, 2020
Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
Journal: Alimentary pharmacology & therapeutics
Published: February 20, 2020
Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis.
Journal: ACG case reports journal
Published: April 13, 2019
The Role of Allergy Testing in Eosinophilic Esophagitis.
Journal: Gastroenterology & hepatology
Published: October 11, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026